JP2014515356A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2014515356A5 JP2014515356A5 JP2014511611A JP2014511611A JP2014515356A5 JP 2014515356 A5 JP2014515356 A5 JP 2014515356A5 JP 2014511611 A JP2014511611 A JP 2014511611A JP 2014511611 A JP2014511611 A JP 2014511611A JP 2014515356 A5 JP2014515356 A5 JP 2014515356A5
- Authority
- JP
- Japan
- Prior art keywords
- composition
- dry powder
- value
- vancomycin
- max
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 239000000203 mixture Substances 0.000 claims 65
- 239000000843 powder Substances 0.000 claims 29
- MYPYJXKWCTUITO-LYRMYLQWSA-N VANCOMYCIN Chemical compound O([C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1OC1=C2C=C3C=C1OC1=CC=C(C=C1Cl)[C@@H](O)[C@H](C(N[C@@H](CC(N)=O)C(=O)N[C@H]3C(=O)N[C@H]1C(=O)N[C@H](C(N[C@@H](C3=CC(O)=CC(O)=C3C=3C(O)=CC=C1C=3)C(O)=O)=O)[C@H](O)C1=CC=C(C(=C1)Cl)O2)=O)NC(=O)[C@@H](CC(C)C)NC)[C@H]1C[C@](C)(N)[C@H](O)[C@H](C)O1 MYPYJXKWCTUITO-LYRMYLQWSA-N 0.000 claims 23
- 229960003165 Vancomycin Drugs 0.000 claims 22
- 108010059993 Vancomycin Proteins 0.000 claims 22
- 150000003839 salts Chemical class 0.000 claims 11
- 239000011780 sodium chloride Substances 0.000 claims 11
- 230000035888 Maximum plasma concentration Effects 0.000 claims 10
- 230000035839 C max Effects 0.000 claims 6
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims 5
- 230000035533 AUC Effects 0.000 claims 4
- 230000036888 Average AUC Effects 0.000 claims 4
- ROHFNLRQFUQHCH-YFKPBYRVSA-N L-leucine Chemical compound CC(C)C[C@H](N)C(O)=O ROHFNLRQFUQHCH-YFKPBYRVSA-N 0.000 claims 4
- 230000037098 T max Effects 0.000 claims 4
- 239000002245 particle Substances 0.000 claims 4
- 230000002685 pulmonary Effects 0.000 claims 4
- 150000001720 carbohydrates Chemical class 0.000 claims 3
- 239000000945 filler Substances 0.000 claims 3
- 239000007787 solid Substances 0.000 claims 3
- HDTRYLNUVZCQOY-WSWWMNSNSA-N Trehalose Natural products O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@H](O)[C@@H](O)[C@@H](O)[C@@H](CO)O1 HDTRYLNUVZCQOY-WSWWMNSNSA-N 0.000 claims 2
- 230000035493 absolute bioavailability Effects 0.000 claims 2
- VUKAUDKDFVSVFT-UHFFFAOYSA-N 2-[6-[4,5-bis(2-hydroxypropoxy)-2-(2-hydroxypropoxymethyl)-6-methoxyoxan-3-yl]oxy-4,5-dimethoxy-2-(methoxymethyl)oxan-3-yl]oxy-6-(hydroxymethyl)-5-methoxyoxane-3,4-diol Chemical compound COC1C(OC)C(OC2C(C(O)C(OC)C(CO)O2)O)C(COC)OC1OC1C(COCC(C)O)OC(OC)C(OCC(C)O)C1OCC(C)O VUKAUDKDFVSVFT-UHFFFAOYSA-N 0.000 claims 1
- FBPFZTCFMRRESA-KAZBKCHUSA-N D-Mannitol Natural products OC[C@@H](O)[C@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-KAZBKCHUSA-N 0.000 claims 1
- GUBGYTABKSRVRQ-UUNJERMWSA-N Lactose Natural products O([C@@H]1[C@H](O)[C@H](O)[C@H](O)O[C@@H]1CO)[C@H]1[C@@H](O)[C@@H](O)[C@H](O)[C@H](CO)O1 GUBGYTABKSRVRQ-UUNJERMWSA-N 0.000 claims 1
- 229920002774 Maltodextrin Polymers 0.000 claims 1
- 239000005913 Maltodextrin Substances 0.000 claims 1
- FBPFZTCFMRRESA-KVTDHHQDSA-N Mannitol Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-KVTDHHQDSA-N 0.000 claims 1
- MUPFEKGTMRGPLJ-ZQSKZDJDSA-N Raffinose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO[C@@H]2[C@@H]([C@@H](O)[C@@H](O)[C@@H](CO)O2)O)O1 MUPFEKGTMRGPLJ-ZQSKZDJDSA-N 0.000 claims 1
- MUPFEKGTMRGPLJ-RMMQSMQOSA-N Raffinose Natural products O(C[C@H]1[C@@H](O)[C@H](O)[C@@H](O)[C@@H](O[C@@]2(CO)[C@H](O)[C@@H](O)[C@@H](CO)O2)O1)[C@@H]1[C@H](O)[C@@H](O)[C@@H](O)[C@@H](CO)O1 MUPFEKGTMRGPLJ-RMMQSMQOSA-N 0.000 claims 1
- HDTRYLNUVZCQOY-LIZSDCNHSA-N Trehalose Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 HDTRYLNUVZCQOY-LIZSDCNHSA-N 0.000 claims 1
- 229960001572 Vancomycin Hydrochloride Drugs 0.000 claims 1
- 150000001413 amino acids Chemical class 0.000 claims 1
- 239000002775 capsule Substances 0.000 claims 1
- 230000002209 hydrophobic Effects 0.000 claims 1
- 239000001866 hydroxypropyl methyl cellulose Substances 0.000 claims 1
- 235000010979 hydroxypropyl methyl cellulose Nutrition 0.000 claims 1
- 229920003088 hydroxypropyl methyl cellulose Polymers 0.000 claims 1
- 239000008101 lactose Substances 0.000 claims 1
- GUBGYTABKSRVRQ-QKKXKWKRSA-N lactose group Chemical group OC1[C@H](O)[C@@H](O)[C@H](O[C@H]2[C@H](O)[C@@H](O)[C@@H](O)[C@H](O2)CO)[C@H](O1)CO GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 claims 1
- 229940035034 maltodextrin Drugs 0.000 claims 1
- 239000000594 mannitol Substances 0.000 claims 1
- 235000010355 mannitol Nutrition 0.000 claims 1
- 238000001694 spray drying Methods 0.000 claims 1
- 125000000647 trehalose group Chemical group 0.000 claims 1
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US201161487971P | 2011-05-19 | 2011-05-19 | |
US61/487,971 | 2011-05-19 | ||
PCT/US2012/038775 WO2012159103A1 (fr) | 2011-05-19 | 2012-05-21 | Compositions de poudre sèche de vancomycine et méthodes associées |
Publications (3)
Publication Number | Publication Date |
---|---|
JP2014515356A JP2014515356A (ja) | 2014-06-30 |
JP2014515356A5 true JP2014515356A5 (fr) | 2015-06-18 |
JP6012716B2 JP6012716B2 (ja) | 2016-10-25 |
Family
ID=47177374
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2014511611A Expired - Fee Related JP6012716B2 (ja) | 2011-05-19 | 2012-05-21 | 乾燥粉末バンコマイシン組成物および関連する方法 |
Country Status (11)
Country | Link |
---|---|
EP (1) | EP2709646A4 (fr) |
JP (1) | JP6012716B2 (fr) |
KR (1) | KR101763195B1 (fr) |
CN (1) | CN103717231B (fr) |
AU (1) | AU2012254999B2 (fr) |
BR (1) | BR112013029803B1 (fr) |
CA (2) | CA2981038C (fr) |
IL (1) | IL229506B (fr) |
MX (1) | MX346244B (fr) |
SG (1) | SG195038A1 (fr) |
WO (1) | WO2012159103A1 (fr) |
Families Citing this family (17)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
ES2594368T3 (es) | 2005-12-08 | 2016-12-19 | Insmed Incorporated | Composiciones a base de lípidos de antiinfecciosos para tratar infecciones pulmonares |
US9119783B2 (en) | 2007-05-07 | 2015-09-01 | Insmed Incorporated | Method of treating pulmonary disorders with liposomal amikacin formulations |
CN104884047A (zh) * | 2012-11-29 | 2015-09-02 | 英斯梅德股份有限公司 | 稳定的万古霉素制剂 |
EP3007689B1 (fr) | 2013-01-10 | 2018-03-07 | Pulmokine, Inc. | Inhibiteurs de kinase non sélectifs |
CN104043104B (zh) * | 2013-03-15 | 2018-07-10 | 浙江创新生物有限公司 | 含盐酸万古霉素的喷雾干粉及其工业化制备方法 |
JP6483714B2 (ja) * | 2013-10-11 | 2019-03-13 | ローレンス エス. ジスマン, | 噴霧乾燥製剤 |
CA2940560A1 (fr) * | 2014-02-28 | 2015-09-03 | Algipharma As | Utilisation d'oligomeres d'alginate pour le traitement de fibrose kystique et d'autres troubles associes a une deficience de fonction de canal ionique cftr |
JP6552528B2 (ja) * | 2014-03-14 | 2019-07-31 | キューティスファーマ インコーポレーテッドCutispharma, Inc. | バンコマイシン経口液体のための組成物および方法 |
CA2949078C (fr) | 2014-05-15 | 2022-09-20 | Insmed Incorporated | Methodes de traitement d'infections pulmonaires mycobacteriennes non-tuberculeuses |
JP6797795B2 (ja) * | 2014-11-06 | 2020-12-09 | クセリア ファーマシューティカルズ エーピーエスXellia Pharmaceuticals ApS | グリコペプチド組成物 |
CN107106585B (zh) * | 2015-02-06 | 2021-01-01 | 杭州美南医药科技有限公司 | 万古霉素的水溶液制剂 |
GB201609940D0 (en) * | 2016-06-07 | 2016-07-20 | Novabiotics Ltd | Microparticles |
WO2018081567A1 (fr) | 2016-10-27 | 2018-05-03 | Pulmokine, Inc. | Polythérapie pour le traitement de l'hypertension pulmonaire |
CN106963939A (zh) * | 2017-03-22 | 2017-07-21 | 永信药品工业(昆山)股份有限公司 | 盐酸万古霉素药物组合物及其制备方法 |
WO2018217800A1 (fr) * | 2017-05-22 | 2018-11-29 | Insmed Incorporated | Composés dérivés de glycopeptides et leurs utilisations |
EP3773505A4 (fr) | 2018-03-30 | 2021-12-22 | Insmed Incorporated | Procédés pour la fabrication continue de produits médicamenteux liposomaux |
WO2020081599A1 (fr) * | 2018-10-15 | 2020-04-23 | Savara Inc. | Séparation de la vancomycine et de ses produits de dégradation |
Family Cites Families (17)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4778054A (en) | 1982-10-08 | 1988-10-18 | Glaxo Group Limited | Pack for administering medicaments to patients |
FI79651C (fi) | 1982-10-08 | 1990-02-12 | Glaxo Group Ltd | Doseringsanordning foer medicin. |
GR861995B (en) | 1985-07-30 | 1986-11-04 | Glaxo Group Ltd | Devices for administering medicaments to patients |
JPH03193735A (ja) * | 1989-12-22 | 1991-08-23 | Shionogi & Co Ltd | グリコペプチド系抗生物質の安定化組成物 |
JPH05963A (ja) | 1990-04-13 | 1993-01-08 | Toray Ind Inc | ポリペプチド類組成物 |
US6582728B1 (en) | 1992-07-08 | 2003-06-24 | Inhale Therapeutic Systems, Inc. | Spray drying of macromolecules to produce inhaleable dry powders |
US6051256A (en) * | 1994-03-07 | 2000-04-18 | Inhale Therapeutic Systems | Dispersible macromolecule compositions and methods for their preparation and use |
JP4142149B2 (ja) * | 1997-07-10 | 2008-08-27 | 明治製菓株式会社 | バンコマイシンの凍結乾燥製剤 |
US6586008B1 (en) * | 1999-08-25 | 2003-07-01 | Advanced Inhalation Research, Inc. | Use of simple amino acids to form porous particles during spray drying |
HU229310B1 (en) * | 1999-10-29 | 2013-10-28 | Nektar Therapeutics | Dry powder compositions having improved dispersivity |
CA2464656C (fr) * | 2001-11-01 | 2013-07-16 | Nektar Therapeutics | Procedes de sechage par atomisation et compositions associees |
DE10358387A1 (de) * | 2003-12-13 | 2005-07-07 | Boehringer Ingelheim Pharma Gmbh & Co. Kg | Pulver enthaltend niedermolekulares Dextran und Verfahren zu deren Herstellung |
FR2872044B1 (fr) * | 2004-06-28 | 2007-06-29 | Flamel Technologies Sa | Formulation pharmaceutique a base d'antibiotique sous forme microcapsulaire |
EP2050437A1 (fr) * | 2007-10-15 | 2009-04-22 | Laboratoires SMB | Compositions de poudre sèche pharmaceutiquement améliorées pour l'inhalation |
HUE038428T2 (hu) * | 2008-10-07 | 2018-10-29 | Horizon Orphan Llc | Aeroszol fluorokinolon készítmények javított farmakokinetika érdekében |
MX354829B (es) * | 2009-03-26 | 2018-03-22 | Pulmatrix Operating Co Inc | Formulaciones de polvo seco y metodos para el tratamiento de enfermedades pulmonares. |
US20120058198A1 (en) * | 2009-03-26 | 2012-03-08 | Pulmatrix, Inc. | Methods for treating and preventing pneumonia and ventilator-associated tracheobronchitis |
-
2012
- 2012-05-21 KR KR1020137033895A patent/KR101763195B1/ko active IP Right Grant
- 2012-05-21 EP EP12785744.9A patent/EP2709646A4/fr not_active Withdrawn
- 2012-05-21 AU AU2012254999A patent/AU2012254999B2/en not_active Ceased
- 2012-05-21 WO PCT/US2012/038775 patent/WO2012159103A1/fr active Application Filing
- 2012-05-21 CA CA2981038A patent/CA2981038C/fr not_active Expired - Fee Related
- 2012-05-21 CA CA2836643A patent/CA2836643C/fr not_active Expired - Fee Related
- 2012-05-21 BR BR112013029803-0A patent/BR112013029803B1/pt not_active IP Right Cessation
- 2012-05-21 SG SG2013085394A patent/SG195038A1/en unknown
- 2012-05-21 MX MX2013013503A patent/MX346244B/es active IP Right Grant
- 2012-05-21 CN CN201280035537.0A patent/CN103717231B/zh not_active Expired - Fee Related
- 2012-05-21 JP JP2014511611A patent/JP6012716B2/ja not_active Expired - Fee Related
-
2013
- 2013-11-19 IL IL229506A patent/IL229506B/en active IP Right Grant
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JP2014515356A5 (fr) | ||
ES2823000T3 (es) | Formulaciones muco-adhesivas de liberación controlada de levodopa y/o ésteres de levodopa y usos de las mismas | |
JP2015509788A5 (fr) | ||
CA2836643C (fr) | Compositions de poudre seche de vancomycine et methodes associees | |
JP2014501224A5 (fr) | ||
JP2011116788A5 (fr) | ||
AU2007267159B2 (en) | Lipoic acid pellets | |
JP2016523250A5 (fr) | ||
JP2016534142A5 (fr) | ||
JP2010537989A5 (fr) | ||
JP2009530415A5 (fr) | ||
JP2011502997A5 (fr) | ||
JP2016500088A5 (fr) | ||
AU2012254999A1 (en) | Dry powder vancomycin compositions and associated methods | |
JP2015007131A5 (fr) | ||
RU2018144108A (ru) | Никотиносодержащие частицы | |
EA031255B1 (ru) | Состав с отсроченным высвобождением, содержащий гранулы цистеамина, и способы его получения и применения | |
WO2018072709A1 (fr) | Composition d'enrobage à base de poudre sèche pour microgranules pharmaceutiques | |
JP2013508289A5 (fr) | ||
JP2013505233A5 (fr) | ||
JP2013523676A5 (fr) | ||
JP2012509922A5 (fr) | ||
JP2011251959A5 (fr) | ||
JPWO2019237028A5 (ja) | 吸入のための組成物 | |
RU2014115289A (ru) | Композиция пазопаниба |